EXPERIENCE

OVER A THOUSAND phase 1 through 4 clinical studies

Oncology and Rare Disease comprise the largest portion of our work, including late-phase trials.

  • Rare Disease portfolio with broad experience across multiple therapeutic areas. Read More
  • A wide variety of studies in hematological malignancies and solid tumor indications. Read More
  • More than 20 NDA / MAA dossiers submitted to global regulatory authorities.
  • Clinical development strategy and complex protocol design consultation across a variety of therapeutic areas.

Phase 1-4

Major Therapeutic Areas
img

Allergy/Pulmonology

img

Cardiology

img

Dermatology

img

Diagnosis & Imaging

img

Endocrinology

img

Gastroenterology

img

Hematology

img

Immunology & Inflammation

img

Infectious Disease

img

Medical Devices

img

Nephrology

img

Neurology

img

Oncology

img

Ophthalmology

img

Orthopedic

img

Pain Medicine

img

Pediatrics

img

Psychiatry

img

Rare Diseases

img

Rheumatology

img

Urology

img

Women's Health

FDA Interactions

PROMETRIKA PhD biostatisticians provide pre-meeting consultation/preparation and meeting participation/presentation for pre-IND, SPA, End-of-Phase 2, pre-NDA, and Advisory Committee meetings.